Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
president: Dr. Jiunn-Lee Lin,
This year again, the Taiwan Society of Cardiology (TSOC) invited the European Society of Cardiology (ESC) to participate to the TSOC annual congress with a joint scientific session. Prof John Camm, FESC, Prof Gregory Lip, FESC and Prof Michel Komajda, FESC were invited to give lectures during this very successful congress! The ESC delegation was warmly welcomed by the President of the Taiwan Society of Cardiology, Dr San-Jou YEH, FESC together with Dr Delon Wu and Prof Chern-En Chiang, FESC.
Atrial fibrillation is a very important issue in both Europe and Taiwan. In the ESC-TSOC Joint Session I, the main theme of the lectures was about atrial fibrllation. There were three invited speekers including Professor John Camm and Professor Gregory YH Lip from ESC and Professor Chern-En Chiang from TSOC.
Professor John Camm gave us a lecture of “Treatment of AF: Where Do We Stand in 2016?” As part of the management cascade of atrial fibrillation, stroke prevention is the main priority. The major guidelines (European, American, NICE, Taiwan) all now recommend use of a risk factor based approach, using the CHA2DS2-VASc score. Professor Gregory YH Lip gave us a lecture of “Antithrombotic Therapy for AF: European Perspectives.” Professor Chern-En Chiang gave us a lecture of “Antithrombotic Therapy for AF: Asian Perspectives.”
Heart failure is one of most common cause of mortality and morbidity in both Europe and Taiwan. In the ESC-TSOC Joint Session II, the main theme of the lectures was about heart failure. There were two invited speekers including Professor Michel Komajda from ESC and Dr. Wei-Chun Huang from TSOC.
Diabetes mellitus is a frequent comorbidity and is observed in about 30 – 40% of patients enrolled in heart failure cohorts. Heart failure is also a major complication of diabetes mellitus; each 1% increase in HbA1C results in about 20% increase of heart failure hospitalizations. Moreover, the coexistence of diabetes mellitus and heart failure is associated with poor outcomes. Professor gave us a lecture of “Diabetes and Heart Failure” In the ESC-TSOC Joint Session II.
Heart failure is one of most common cause of death in Taiwan. Heart failure is the major terminal pathway for different cardiovascular diseases. Due to aging population and improved care of underlying cardiovascular diseases, the population of heart failure increases in Taiwan in recent years.
The pharmacological, non-pharmacological treatments and therapeutic strategies were demonstrated to be beneficial for patients with heart failure in recent randomized clinical trials. However, the treatment of heart failure remains a major challenge in Taiwan. Dr. Wei-Chun Huang gave a lecture of “The Treatment of Heart Failure in Taiwan” in this ESC-TSOC Joint Session II.
President: Dr Jiunn-Lee Lin, FESC
1st Vice-President: Prof Ju-Pin PAN
2nd Vice-President: Prof Wei-Hsian YIN
Past-President: Dr San-Jou YEH, FESC
(for a full list of board members, please visit the society's web site)Number of members: 1700
Year of Foundation: 1960
Year of ESC affiliation: 2008
Taiwan Society of Cardiology (TSOC) aims to promote cardiology research, teaching, prevention and treatment. TSOC promotes cardiology research, sponsors academic lectures and seminars, trains cardiology specialists and helps the government review policies and guidelines for the treatment of cardiac diseases. The number of the TSOC Members is growing at a steady pace of 50 additional members every year. TSOC has set up a total of seventeen committees.
TSOC sponsors approximately 30 academic seminars educational and training programs every year. In May of each year, TSOC holds a two-day academic seminar at Taipei International Conference Center which is attended by scholars and experts locally and internationally. There were more than 200 abstracts presented every year. About forty local and foreign companies exhibit up-to-date medical equipment and drugs in each event.
Cardiovascular Specialist Doctors in internal medicine, surgery or pediatrics must satisfactorily complete educational & training programs of the cardiovascular specialty in accredited teaching hospitals for two years and pass the TSOC examinations before being accredited as Cardiovascular Specialist Doctors. The TSOC examinations for Cardiovascular Specialist Doctors, held during September - October every year, consist of both written and oral examinations. Examinees must pass written examinations before the oral tests. The written examinations last for three hours with 200 questions in multiple choices, the contents of which include Basic, Common and General cardiology in internal medicine, surgery and, pediatrics. In the oral examination, examinees are examined by 5~7 professional examiners. Currently the passing rate is approximately 75% but is scheduled to be reduced year-by-year.
Taiwan Society of Cardiology
13F-1, No. 11, Min-Chuan West Road
Tel. +886 2 25976177
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved